[Hinews] SEOUL, South Korea — Samsung Seoul Hospital has been named the world’s third-best hospital for cancer care in the 2026 World’s Best Specialized Hospitals rankings, a collaborative evaluation by Newsweek and German market research firm Statista. This marks the hospital’s second consecutive year in the top three, trailing only two U.S.-based cancer specialists: Memorial Sloan Kettering Cancer Center, which took first place, and MD Anderson Cancer Center, which secured second. Among general hospitals, Samsung Seoul achieved the highest global ranking and maintained its position as the top hospital in the Asia-Pacific region for the fourth straight year.

The Newsweek rankings, compiled based on evaluations from medical professionals and experts across multiple countries, underwent rigorous review by an advisory board before final publication. Samsung Seoul Hospital distinguished itself across several medical specialties. In respiratory care, it ranked 19th globally and first in South Korea for the third consecutive year. The hospital also placed fifth in digestive diseases and tenth in urology, with a total of 12 clinical departments ranking within the global top 100.

In the smart hospital category, which assesses medical IT infrastructure and the adoption of digital technologies, Samsung Seoul retained its domestic lead for the fifth consecutive year and climbed three spots to 15th globally. The hospital has implemented a digital twin-based operating system, known as DOCC, to simulate resource allocation and patient flow, enhancing operational efficiency in real-world clinical settings.

Exterior view of Samsung Seoul Hospital (Photo provided by Samsung Seoul Hospital)
Exterior view of Samsung Seoul Hospital (Photo provided by Samsung Seoul Hospital)

Samsung Seoul has made significant strides in oncology, particularly in precision medicine. In 2022, the hospital treated approximately 30,000 cancer patients, achieving a five-year survival rate of 75%. For lung cancer specifically, the hospital reported a five-year relative survival rate of 63.6%. The institution has also built a robust database for precision cancer care and consistently documented treatment outcomes across various cancer types.

In respiratory medicine, Samsung Seoul performs a high volume of complex procedures, including endobronchial ultrasound and lung biopsies, while contributing to the field through ongoing research publications.

Hospital President Seung-Woo Park emphasized the significance of the recognition. “This evaluation provided an opportunity for our clinical practices and operational systems to be scrutinized on an international stage,” Park said. “We are committed to continuous improvement and collaboration moving forward.”

The hospital’s achievements underscore South Korea’s growing prominence in global healthcare, with Samsung Seoul leading the charge in both clinical excellence and technological innovation.
저작권자 © Hinews 무단전재 및 재배포 금지
ad